Annual Net Income
-$2.63 M
-$2.27 M-638.48%
December 31, 2023
Summary
- As of February 7, 2025, BGLC annual net profit is -$2.63 million, with the most recent change of -$2.27 million (-638.48%) on December 31, 2023.
- During the last 3 years, BGLC annual net income has fallen by -$3.72 million (-340.29%).
- BGLC annual net income is now -340.29% below its all-time high of $1.09 million, reached on December 1, 2020.
Performance
BGLC Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$1.35 M
-$1.54 M-775.74%
September 30, 2024
Summary
- As of February 7, 2025, BGLC quarterly net profit is -$1.35 million, with the most recent change of -$1.54 million (-775.74%) on September 30, 2024.
- Over the past year, BGLC quarterly net income has dropped by -$1.54 million (-775.74%).
- BGLC quarterly net income is now -225.79% below its all-time high of $1.07 million, reached on March 1, 2020.
Performance
BGLC Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$941.60 K
+$1.26 M+57.30%
September 30, 2024
Summary
- As of February 7, 2025, BGLC TTM net profit is -$941.60 thousand, with the most recent change of +$1.26 million (+57.30%) on September 30, 2024.
- Over the past year, BGLC TTM net income has increased by +$1.26 million (+57.30%).
- BGLC TTM net income is now -180.09% below its all-time high of $1.18 million, reached on September 1, 2020.
Performance
BGLC TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
BGLC Net Income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -638.5% | -775.7% | +57.3% |
| 3 y3 years | -340.3% | -1847.0% | -112.9% |
| 5 y5 years | -10000.0% | -1847.0% | -112.9% |
BGLC Net Income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -449.8% | at low | -536.1% | +48.4% | -225.3% | +69.6% |
| 5 y | 5-year | -340.3% | at low | -225.8% | +48.4% | -180.1% | +69.6% |
| alltime | all time | -340.3% | at low | -225.8% | +48.4% | -180.1% | +69.6% |
BioNexus Gene Lab Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.35 M(-775.7%) | -$941.60 K(-57.3%) |
| Jun 2024 | - | $199.10 K(-291.8%) | -$2.21 M(-17.2%) |
| Mar 2024 | - | -$103.80 K(-133.6%) | -$2.66 M(+1.3%) |
| Dec 2023 | -$2.63 M(+638.5%) | $308.50 K(-111.8%) | -$2.63 M(-15.0%) |
| Sep 2023 | - | -$2.61 M(+906.2%) | -$3.09 M(+449.9%) |
| Jun 2023 | - | -$259.30 K(+275.3%) | -$562.80 K(+27.3%) |
| Mar 2023 | - | -$69.10 K(-56.0%) | -$442.20 K(+24.2%) |
| Dec 2022 | -$356.00 K(-147.4%) | -$157.00 K(+102.8%) | -$356.00 K(+224.2%) |
| Sep 2022 | - | -$77.40 K(-44.2%) | -$109.80 K(-141.8%) |
| Jun 2022 | - | -$138.70 K(-911.1%) | $262.90 K(-38.8%) |
| Mar 2022 | - | $17.10 K(-80.8%) | $429.90 K(-42.8%) |
| Dec 2021 | $751.60 K | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | $89.20 K(-69.8%) | $751.50 K(+54.0%) |
| Sep 2021 | - | $295.30 K(+943.5%) | $488.10 K(+14.2%) |
| Jun 2021 | - | $28.30 K(-91.6%) | $427.30 K(+17.6%) |
| Mar 2021 | - | $338.70 K(-294.4%) | $363.20 K(-66.8%) |
| Dec 2020 | $1.09 M(-543.9%) | -$174.20 K(-174.3%) | $1.09 M(-6.9%) |
| Sep 2020 | - | $234.50 K(-755.0%) | $1.18 M(+27.9%) |
| Jun 2020 | - | -$35.80 K(-103.3%) | $919.20 K(+3.9%) |
| Mar 2020 | - | $1.07 M(-1255.1%) | $884.60 K(-458.9%) |
| Dec 2019 | -$246.50 K(-1030.2%) | -$92.60 K(+320.9%) | -$246.50 K(+60.2%) |
| Sep 2019 | - | -$22.00 K(-68.8%) | -$153.90 K(+16.7%) |
| Jun 2019 | - | -$70.40 K(+14.5%) | -$131.90 K(+114.5%) |
| Mar 2019 | - | -$61.50 K | -$61.50 K |
| Dec 2018 | $26.50 K | - | - |
FAQ
- What is BioNexus Gene Lab annual net profit?
- What is the all time high annual net income for BioNexus Gene Lab?
- What is BioNexus Gene Lab annual net income year-on-year change?
- What is BioNexus Gene Lab quarterly net profit?
- What is the all time high quarterly net income for BioNexus Gene Lab?
- What is BioNexus Gene Lab quarterly net income year-on-year change?
- What is BioNexus Gene Lab TTM net profit?
- What is the all time high TTM net income for BioNexus Gene Lab?
- What is BioNexus Gene Lab TTM net income year-on-year change?
What is BioNexus Gene Lab annual net profit?
The current annual net income of BGLC is -$2.63 M
What is the all time high annual net income for BioNexus Gene Lab?
BioNexus Gene Lab all-time high annual net profit is $1.09 M
What is BioNexus Gene Lab annual net income year-on-year change?
Over the past year, BGLC annual net profit has changed by -$2.27 M (-638.48%)
What is BioNexus Gene Lab quarterly net profit?
The current quarterly net income of BGLC is -$1.35 M
What is the all time high quarterly net income for BioNexus Gene Lab?
BioNexus Gene Lab all-time high quarterly net profit is $1.07 M
What is BioNexus Gene Lab quarterly net income year-on-year change?
Over the past year, BGLC quarterly net profit has changed by -$1.54 M (-775.74%)
What is BioNexus Gene Lab TTM net profit?
The current TTM net income of BGLC is -$941.60 K
What is the all time high TTM net income for BioNexus Gene Lab?
BioNexus Gene Lab all-time high TTM net profit is $1.18 M
What is BioNexus Gene Lab TTM net income year-on-year change?
Over the past year, BGLC TTM net profit has changed by +$1.26 M (+57.30%)